548 filings
8-K
MDXG
Mimedx Group Inc
27 Mar 24
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
8:24am
8-K
MDXG
Mimedx Group Inc
4 Mar 24
MIMEDX Announces Appointment of Two New Independent Directors
8:11am
8-K
MDXG
Mimedx Group Inc
28 Feb 24
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
4:22pm
10-K
2023 FY
MDXG
Mimedx Group Inc
Annual report
28 Feb 24
4:02pm
8-K
MDXG
Mimedx Group Inc
22 Jan 24
MIMEDX Announces Improved Capital Structure with New Senior
8:09am
8-K
a4rk jscpi
28 Dec 23
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock
4:30pm
8-K
aou3nkl2q8kaj6 j9u6x
13 Nov 23
MIMEDX to Participate in Upcoming Investor Conferences
8:14am
8-K
ew850
30 Oct 23
MIMEDX Announces Third Quarter 2023 Operating and Financial Results
4:05pm
8-K
xoshxkw1m ezdxddnvnj
5 Sep 23
Departure of Directors or Certain Officers
5:00pm
8-K
mtb32ak0l
5 Sep 23
MIMEDX to Present at Upcoming Investor Conferences
8:38am
8-K
hkh pw8wlfa
1 Aug 23
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
4:03pm
S-8
edv4nv9
25 Jul 23
Registration of securities for employees
4:22pm
S-8
bgpmyrufbc9 721dlgy
25 Jul 23
Registration of securities for employees
4:19pm
8-K
7f5xdqsmtdtyevs67f0
5 Jul 23
MIMEDX Appoints Doug Rice as Chief Financial Officer
9:02am
8-K
drmkdknc2j7kocne
20 Jun 23
Departure of Directors or Certain Officers
4:03pm
8-K
63stjo1n4aalczk01i09
14 Jun 23
Departure of Directors or Certain Officers
4:23pm